Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gergely

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Neoplasma|May 23, 2015
Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (Chemotherapy Effectiveness Assessment by PET/CT) study - long term observationZ Miltenyi, S Barna, I Garai, et al.
Medical Microbiology and Immunology|September 14, 2012
Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infectionStefan Ebert, Jürgen Podlech, Dorothea Gillert-Marien, et al.
Frontiers in Immunology|September 7, 2021
Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus InfectionKerstin M Gergely, Jürgen Podlech, Sara Becker, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|January 17, 2003
Adult blood lead epidemiology and surveillance--United States, 1998-2001Robert J Roscoe, Wayne Ball, John J Curran, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Neoplasma|May 23, 2015
Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (Chemotherapy Effectiveness Assessment by PET/CT) study - long term observationZ Miltenyi, S Barna, I Garai, et al.
Medical Microbiology and Immunology|September 14, 2012
Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infectionStefan Ebert, Jürgen Podlech, Dorothea Gillert-Marien, et al.
Frontiers in Immunology|September 7, 2021
Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus InfectionKerstin M Gergely, Jürgen Podlech, Sara Becker, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|January 17, 2003
Adult blood lead epidemiology and surveillance--United States, 1998-2001Robert J Roscoe, Wayne Ball, John J Curran, et al.
Pageof 7